Literature DB >> 19569082

A screen of SLC1A1 for OCD-related alleles.

Y Wang1, A Adamczyk2, Y Y Shugart3, J F Samuels1, M A Grados1, B D Greenberg4, J A Knowles5, J T McCracken6, S L Rauch7, D L Murphy8, S A Rasmussen4, B Cullen1, A Pinto9, A J Fyer9, J Piacentini6, D L Pauls7, O J Bienvenu1, M Riddle1, K Y Liang10, D Valle2, T Wang2, G Nestadt1.   

Abstract

SLC1A1, which encodes the neuronal and epithelial glutamate transporter, is a promising candidate gene for obsessive-compulsive disorder (OCD). In this study, we conducted capillary electrophoresis single-strand conformation polymorphism (CE-SSCP) screen for all 12 identified exons, including all coding regions and approximately 50 bp of flanking introns of the human SLC1A1 in 378 OCD-affected individuals. Full sequencing was completed on samples that showed an aberrant SSCP tracing for identification of the underlying sequence variants. Our aim was to determine if there are differences in the frequencies of relatively common alleles, or rare functional alleles, in 378 OCD cases and 281 ethnically matched controls. We identified one nonsynonymous coding SNP (c.490A > G, T164A) and three synonymous coding SNP (c.81G > C, A27A; c.414A > G, T138T; c.1110T > C, T370T) in case samples. We found no statistical differences in genotype and allele frequencies of common cSNPs in SLC1A1 between the OCD cases and controls. The rare variant T164A was found only in one family. Further investigation of this variant is necessary to determine whether and how it is related to OCD. There was no other evidence of significant accumulation of deleterious coding mutations in SLC1A1 in the OCD cases. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19569082     DOI: 10.1002/ajmg.b.31001

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  24 in total

1.  Functional studies and rare variant screening of SLC1A1/EAAC1 in males with obsessive-compulsive disorder.

Authors:  Jeremy Veenstra-VanderWeele; Tim Xu; Alicia M Ruggiero; Lauren R Anderson; Shaine T Jones; Joseph A Himle; James L Kennedy; Margaret A Richter; Gregory L Hanna; Paul D Arnold
Journal:  Psychiatr Genet       Date:  2012-10       Impact factor: 2.458

Review 2.  Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Opin Neurobiol       Date:  2011-05-24       Impact factor: 6.627

Review 3.  Learning From Animal Models of Obsessive-Compulsive Disorder.

Authors:  Patricia Monteiro; Guoping Feng
Journal:  Biol Psychiatry       Date:  2015-05-04       Impact factor: 13.382

4.  Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder.

Authors:  Pino Alonso; Mónica Gratacós; Cinto Segalàs; Georgia Escaramís; Eva Real; Mónica Bayés; Javier Labad; Clara López-Solà; Xavier Estivill; José M Menchón
Journal:  J Psychiatry Neurosci       Date:  2012-07       Impact factor: 6.186

5.  Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder.

Authors:  Jack Samuels; Ying Wang; Mark A Riddle; Benjamin D Greenberg; Abby J Fyer; James T McCracken; Scott L Rauch; Dennis L Murphy; Marco A Grados; James A Knowles; John Piacentini; Bernadette Cullen; O Joseph Bienvenu; Steven A Rasmussen; Daniel Geller; David L Pauls; Kung-Yee Liang; Yin Y Shugart; Gerald Nestadt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-03-28       Impact factor: 3.568

6.  Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria.

Authors:  Charles G Bailey; Renae M Ryan; Annora D Thoeng; Cynthia Ng; Kara King; Jessica M Vanslambrouck; Christiane Auray-Blais; Robert J Vandenberg; Stefan Bröer; John E J Rasko
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

7.  Neuronal excitatory amino acid transporter EAAT3: Emerging functions in health and disease.

Authors:  Suzanne M Underhill; Susan L Ingram; Susanne E Ahmari; Jeremy Veenstra-VanderWeele; Susan G Amara
Journal:  Neurochem Int       Date:  2018-05-22       Impact factor: 3.921

Review 8.  The importance of the excitatory amino acid transporter 3 (EAAT3).

Authors:  Walden E Bjørn-Yoshimoto; Suzanne M Underhill
Journal:  Neurochem Int       Date:  2016-05-24       Impact factor: 3.921

9.  Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive-compulsive disorder.

Authors:  Swarup Mitra; Abel Bult-Ito
Journal:  Behav Pharmacol       Date:  2018-06       Impact factor: 2.293

Review 10.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.